Zeillinger R - Search Results

1

An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.

Hefler LA, Grimm C, Ackermann S, Malur S, Radjabi-Rahat AR, Leodolter S, Beckmann MW, Zeillinger R, Koelbl H, Tempfer CB. Hefler LA, et al. Among authors: zeillinger r. Cancer Res. 2003 Jun 15;63(12):3066-8. Cancer Res. 2003. PMID: 12810629

2

Quantification of uPA receptor expression in human breast cancer cell lines by cRT-PCR.

Sliutz G, Eder H, Koelbl H, Tempfer C, Auerbach L, Schneeberger C, Kainz C, Zeillinger R. Sliutz G, et al. Among authors: zeillinger r. Breast Cancer Res Treat. 1996;40(3):257-63. doi: 10.1007/BF01806814. Breast Cancer Res Treat. 1996. PMID: 8883968

3

The serum tumor marker M3/M21 in the follow-up of breast cancer patients.

Tempfer C, Hanzal E, Zeillinger R, Koelbl H, Dadak C, Kainz C. Tempfer C, et al. Among authors: zeillinger r. Anticancer Res. 1996 Sep-Oct;16(5B):3049-52. Anticancer Res. 1996. PMID: 8920765

4

Detection of p53 point mutations in primary human vulvar cancer by PCR and temperature gradient gel electrophoresis.

Sliutz G, Schmidt W, Tempfer C, Speiser P, Gitsch G, Eder S, Schneeberger C, Kainz C, Zeillinger R. Sliutz G, et al. Among authors: zeillinger r. Gynecol Oncol. 1997 Jan;64(1):93-8. doi: 10.1006/gyno.1996.4535. Gynecol Oncol. 1997. PMID: 8995554

5

EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.

Fischer-Colbrie J, Witt A, Heinzl H, Speiser P, Czerwenka K, Sevelda P, Zeillinger R. Fischer-Colbrie J, et al. Among authors: zeillinger r. Anticancer Res. 1997 Jan-Feb;17(1B):613-9. Anticancer Res. 1997. PMID: 9066588

6

pS2 and PAI-1 in ovarian cancer: correlation to pathohistological parameters.

Speiser P, Mayerhofer K, Kucera E, Roch G, Mittelböck M, Gitsch G, Zeillinger R. Speiser P, et al. Among authors: zeillinger r. Anticancer Res. 1997 Jan-Feb;17(1B):679-83. Anticancer Res. 1997. PMID: 9066601

7

Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival.

Obermair A, Kucera E, Mayerhofer K, Speiser P, Seifert M, Czerwenka K, Kaider A, Leodolter S, Kainz C, Zeillinger R. Obermair A, et al. Among authors: zeillinger r. Int J Cancer. 1997 Aug 22;74(4):455-8. doi: 10.1002/(sici)1097-0215(19970822)74:4<455::aid-ijc17>3.0.co;2-8. Int J Cancer. 1997. PMID: 9291439

8

Serum M3/M21 in cervical cancer patients.

Sliutz G, Tempfer C, Hanzal E, Reinthaller A, Koelbl H, Zeillinger R, Kainz C. Sliutz G, et al. Among authors: zeillinger r. Eur J Cancer. 1997 May;33(6):973-5. doi: 10.1016/s0959-8049(96)00519-9. Eur J Cancer. 1997. PMID: 9291824

9

Quantitative determination of gene expression by competitive reverse transcription-polymerase chain reaction in degraded RNA samples.

Tong D, Schneeberger C, Leodolter S, Zeillinger R. Tong D, et al. Among authors: zeillinger r. Anal Biochem. 1997 Sep 5;251(2):173-7. doi: 10.1006/abio.1997.2280. Anal Biochem. 1997. PMID: 9299013

10

Prostate specific antigen (PSA) in breast and ovarian cancer.

Kucera E, Kainz C, Tempfer C, Zeillinger R, Koelbl H, Sliutz G. Kucera E, et al. Among authors: zeillinger r. Anticancer Res. 1997 Nov-Dec;17(6D):4735-7. Anticancer Res. 1997. PMID: 9494598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters